AIkido Pharma: Funding, Investors & Team (Aug 2026)
The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipe to treat unmet medical needs in oncology.
AIkido Pharma has raised $22.0M across 1 funding round on record, the most recent a Post-IPO Equity of $22.0M announced in Feb 2022.
That round is above the $10M median round size for Hardware companies tracked on FundedIQ over the last two years.
AIkido Pharma Company Profile and Key Stats
Latest funding round on record: Feb 2022.
AIkido Pharma Funding Rounds
AIkido Pharma Founders and Leadership Team
No contact details are on record for this team yet.
AIkido Pharma Funding Compared to Other Hardware Startups
AIkido Pharma's latest round of $22.0M is above the median round in Hardware. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AIkido Pharma in Hardware and Washington
Companies Similar to AIkido Pharma
Relativity Networks is the leading supplier of Hollow Core Fiber technology, which greatly enhances the speed…
Oxide Computer Company produces server racks designed for on-site computer systems. Employing advanced…
Aligned Data Centers is a prominent technology infrastructure firm that provides cutting-edge and flexible…
LeapXpert enables enterprises to embrace consumer messaging applications and integrate them into their…
Prime Data Centers offers purpose-built data center development with unique customer partnership options and…
Now in its fourth year, #GivingTuesday is a global day of giving fueled by the power of social media and…
Duos Technologies provides intelligent video surveillance software featuring video analytics, as well as…
Memory Store is a platform that offers a shared memory storage space for office teams and workforce.
Agni's objective is to transform computing by delivering breakthrough memory solutions with unparalleled…
Hydra Host is a tool that provides cross-cloud capabilities to deploy and host apps across public cloud and…
PointFive enables continuous cloud cost efficiency through our proprietary DeepWaste™ technology, designed to…
Duos Edge AI delivers adaptive edge data center solutions for digital infrastructure and connectivity across…
AIkido Pharma Funding FAQs
What does AIkido Pharma do?
The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipe to treat unmet medical needs in oncology.
How much funding has AIkido Pharma raised?
AIkido Pharma has raised $22.0M across 1 round on record. The most recent is a Post-IPO Equity of $22.0M announced in Feb 2022.
When did AIkido Pharma last raise funding?
AIkido Pharma's most recent funding round on record is a Post-IPO Equity of $22.0M, announced in Feb 2022.
Who is the CEO of AIkido Pharma?
Anthony Hayes is listed as CEO at AIkido Pharma.
Where is AIkido Pharma headquartered?
AIkido Pharma is based in Washington, District of Columbia, United States.
How many employees does AIkido Pharma have?
AIkido Pharma is in the 1-10 employee band.
How does AIkido Pharma's funding compare to other Hardware startups?
AIkido Pharma's latest round of $22.0M is above the $10M median round size for Hardware companies on FundedIQ across 1,454 tracked companies over the last two years.
About FundedIQ's AIkido Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AIkido Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.